COHBAR, INC. (OTCMKTS:CWBR) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

COHBAR, INC. (OTCMKTS:CWBR) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Story continues below

On April 26, 2018, CohBar, Inc. (the “Company”) received written notice from the NASDAQ Stock Market (“NASDAQ”) stating that the Company is not in compliance with the audit committee requirements for continued listing on the NASDAQ Capital Market, as set forth in NASDAQ Listing Rule 5605 (the “Audit Committee Requirements”), following the resignation of Marc Goldberg from the Company’s Board of Directors and Audit Committee on April 16, 2018. The notice has no immediate effect on the listing of the Company's common stock, and its common stock will continue to trade on the NASDAQ Capital Market under the symbol “CWBR” at this time. In accordance with NASDAQ Listing Rule 5605(c)(4), the Company has a cure period to regain compliance with the Audit Committee Requirements ending on the later of (i) the date of its next annual meeting of stockholders or April 15, 2019; or (ii) if the next annual stockholders meeting is held before October 15, 2018, then October 15, 2018. Mr. Goldberg’s resignation left the Company’s Audit Committee with only two independent members. To regain compliance, the Company’s Board of Directors must appoint an additional independent director, as defined under applicable NASDAQ rules, to the Audit Committee before the expiration of the cure period.

If the Company does not regain compliance with Audit Committee Requirements by October 15, 2018, NASDAQ will provide written notification to the Company that its securities will be subject to delisting. The Company is currently searching for and evaluating candidates for appointment as an independent director to its Board of Directors and Audit Committee prior to the expiration of the cure period.

An ad to help with our costs